Your browser doesn't support javascript.
loading
Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.
Mave, V; Meshram, S; Lokhande, R; Kadam, D; Dharmshale, S; Bharadwaj, R; Kagal, A; Pradhan, N; Deshmukh, S; Atre, S; Sahasrabudhe, T; Barthwal, M; Meshram, S; Kakrani, A; Kulkarni, V; Raskar, S; Suryavanshi, N; Shivakoti, R; Chon, S; Selvin, E; Gupte, A; Gupta, A; Gupte, N; Golub, J E.
Afiliação
  • Mave V; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Meshram S; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Lokhande R; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Kadam D; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Dharmshale S; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Bharadwaj R; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Kagal A; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Pradhan N; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Deshmukh S; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Atre S; Dr D Y Patil Medical College, Pune, India.
  • Sahasrabudhe T; Dr D Y Patil Medical College, Pune, India.
  • Barthwal M; Dr D Y Patil Medical College, Pune, India.
  • Meshram S; Dr D Y Patil Medical College, Pune, India.
  • Kakrani A; Dr D Y Patil Medical College, Pune, India.
  • Kulkarni V; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Raskar S; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Suryavanshi N; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Shivakoti R; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Chon S; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Selvin E; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Gupte A; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Gupta A; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gupte N; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Golub JE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Int J Tuberc Lung Dis ; 21(12): 1280-1287, 2017 12 01.
Article em En | MEDLINE | ID: mdl-29297449
ABSTRACT

SETTING:

Pune, India.

OBJECTIVES:

To estimate the prevalence and risk factors of pre-diabetes mellitus (DM) and DM, and its associations with the clinical presentation of tuberculosis (TB).

DESIGN:

Screening for DM was conducted among adults (age  18 years) with confirmed TB between December 2013 and January 2017. We used multinomial regression to evaluate the risk factors for pre-DM (glycated hemoglobin [HbA1c]  5.7-6.5% or fasting glucose 100-125 mg/dl) and DM (HbA1c  6.5% or fasting glucose  126 mg/dl or random blood glucose > 200 mg/dl or self-reported DM history/treatment) and the association of dysglycemia with the severity of TB disease.

RESULTS:

Among 1793 participants screened, 890 (50%) had microbiologically confirmed TB. Of these, 33% had pre-DM and 18% had DM; 41% were newly diagnosed. The median HbA1c level among newly diagnosed DM was 7.0% vs. 10.3% among known DM (P < 0.001). DM (adjusted OR [aOR] 4.94, 95%CI 2.33-10.48) and each per cent increase in HbA1c (aOR 1.42, 95%CI 1.01-2.01) was associated with >1+ smear grade or 9 days to TB detection.

CONCLUSION:

Over half of newly diagnosed TB patients had DM or pre-DM. DM and increasing dysglycemia was associated with higher bacterial burden at TB diagnosis, potentially indicating a higher risk of TB transmission to close contacts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Tuberculose Pulmonar / Glicemia / Programas de Rastreamento Tipo de estudo: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Tuberculose Pulmonar / Glicemia / Programas de Rastreamento Tipo de estudo: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article